Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02796391 · ClinicalTrials.gov registry record · Phase 2
Facilitating Smoking Cessation With Reduced Nicotine Cigarettes
A Phase 2 study of Smoking Cessation, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 163
- Enrollment target
- 1
- Study location
NCT02796391 is a Phase 2 study of Smoking Cessation that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 163 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02796391, a Phase 2 study of Smoking Cessation, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 163 participants
- Enrollment target
- 1
- Study location
Study Summary
STUDY 1: INTERVENTION DEVELOPMENT The purpose of this study is to determine the best way to help people stop smoking by using very low nicotine content (VLNC) cigarettes. This developmental pilot study (n=20) will determine the feasibility of the treatment approach and methodology using a targeted intervention, and lead to refinements for a subsequent randomized controlled trial (RCT). STUDY 2: RANDOMIZED CONTROLLED TRIAL The purpose of this study is to see if a targeted intervention will help people to stop or reduce smoking better than a standard intervention using very low nicotine content (VLNC) cigarettes, and to determine the optimal nicotine tapering schedule (gradual vs. immediate) during a 5-week pre-quit period. About 208 participants will take part in this phase of the study at Moffitt Cancer Center.
Conditions Studied
Interventions
- DRUG Very Low Nicotine Content (VLNC) Cigarettes
- BEHAVIORAL One on One Counseling
Study Locations (1)
Florida
- H. Lee Moffitt Cancer Center and Research Institute - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2017-09-07 |
| Est. Completion | 2021-08-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02796391
The ClinicalTrials.gov registry entry for NCT02796391 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (66% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Very Low Nicotine Content (VLNC) Cigarettes is the first listed.
NCT02796391 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02796391 about?
NCT02796391 is a clinical study titled "Facilitating Smoking Cessation With Reduced Nicotine Cigarettes". STUDY 1: INTERVENTION DEVELOPMENT The purpose of this study is to determine the best way to help people stop smoking by using very low nicotine content (VLNC) cigarettes. This developmental pilot study (n=20) will determine the feasibility of the treatment approach and methodology using a targeted i...
What is the current status of trial NCT02796391?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 163 participants. The study started on 2017-09-07. Estimated completion is 2021-08-24.
What conditions does trial NCT02796391 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT02796391?
The interventions under investigation include: Very Low Nicotine Content (VLNC) Cigarettes (DRUG), One on One Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02796391?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02796391 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
-
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
RECRUITING · Phase 2
-
Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate
COMPLETED · Phase 2
-
Treating Smokers With Mental Illness
COMPLETED · Phase 2
-
Suvorexant to Reduce Symptoms of Nicotine Use
COMPLETED · Phase 2
-
Pharmacogenetics, Emotional Reactivity and Smoking
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.